Last reviewed · How we verify
terbutaline sulphate metered dose — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
terbutaline sulphate metered dose (terbutaline sulphate metered dose) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| terbutaline sulphate metered dose TARGET | terbutaline sulphate metered dose | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- terbutaline sulphate metered dose CI watch — RSS
- terbutaline sulphate metered dose CI watch — Atom
- terbutaline sulphate metered dose CI watch — JSON
- terbutaline sulphate metered dose alone — RSS
Cite this brief
Drug Landscape (2026). terbutaline sulphate metered dose — Competitive Intelligence Brief. https://druglandscape.com/ci/terbutaline-sulphate-metered-dose. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab